<i>Panax ginseng</i> as a potential therapeutic for neurological disorders associated with COVID-19; Toward targeting inflammasome.

Authors:
Shin SW; Cho IH.

Journal:
J Ginseng Res

Publication Year: 2022

DOI:
10.1016/j.jgr.2022.09.004

PMCID:
PMC9529349

PMID:
36213093

Journal Information

Full Title: J Ginseng Res

Abbreviation: J Ginseng Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"This research was supported by Basic Science Research Program through the 10.13039/501100003725National Research Foundation of Korea (NRF) funded by the Ministry of Science, and ICT (NRF-2022R1A2C2009817). This research was also performed by Independent Learning and Research Program and Undergraduate Research Assistant Program in Kyung Hee University (2021)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025